A
SPRY
ARS Pharms
7.41
+0.11+1.44%Opening09:55 05/19 EDT
OPEN/PREV CLOSE8.23/8.23
TODAY RANGE7.91-8.29
VOL2.49M
MARKET CAP788.47M
52 WEEK RANGE6.66-18.90
AVG VOL (3M)1.63M
% TURNOVER2.50%
TURNOVER--
P/E (TTM)-3.9664
% RANGE4.62%
EPS(TTM)-2.0018
P/E(FORWARD)-4.0510
P/B12.86
BVPS0.6174
DIVIDEND--
P/S9.35
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP594.18M
SHARES OUTSTANDING99.30M
NEXT EARNINGS08/11-08/17
FREE FLOAT74.83M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
ARS Pharmaceuticals: Still A Buy As Neffy Access Improves
TipRanks·05/15 20:27
Third Point buys Meta, exits PG&E in Q1
Benzinga·05/15 20:26
Third Point Increases Stake In ARS Pharmaceuticals To 1,000,000 Shares
Reuters·05/15 17:46
BUZZ-U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark
Reuters·05/15 16:36
BUZZ-U.S. STOCKS ON THE MOVE-Exxon Mobil, Intel, Nvidia
TipRanks·05/15 16:00
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
TipRanks·05/15 15:17
Morning Movers: Cerebras Systems pulls back after smash IPO
Benzinga·05/15 13:31
ARS Pharmaceuticals Q1 2026 Earnings Call Transcript
Reuters·05/15 13:11
BUZZ-U.S. STOCKS ON THE MOVE-Shutterstock, RXO, Microsoft
Dow Jones·05/15 11:59
ARS Pharmaceuticals Shares Fall on Wider 1Q Loss as Expenses Rise
Reuters·05/15 11:52
BUZZ-U.S. STOCKS ON THE MOVE-Cerebras, Papa John's, airline stocks
Benzinga·05/15 11:11
Earnings Scheduled For May 15, 2026
Same Industry
Name/Symbol
Change%
Price